Autor: |
Vali Betts E; Department of Pathology and Laboratory Medicine, University of California, Davis, 4400 V Street, Sacramento, CA 95817, USA., Rashidi HH; Department of Pathology and Laboratory Medicine, University of California, Davis, 4400 V Street, Sacramento, CA 95817, USA. |
Jazyk: |
angličtina |
Zdroj: |
Case reports in hematology [Case Rep Hematol] 2016; Vol. 2016, pp. 5415974. Date of Electronic Publication: 2016 Sep 28. |
DOI: |
10.1155/2016/5415974 |
Abstrakt: |
Diffuse large B-cell lymphoma (DLBCL) is a neoplasm of large B-lymphocytes with a diffuse growth pattern. The neoplastic cells express B-cell markers such as CD20 and PAX-5 and there may be coexpression of BCL-2, BCL-6, CD10, and MUM-1. With the exception of CD5, other T-cell markers are not commonly expressed in this neoplasm. Here, we describe the first reported case of a DLBCL with abnormal expression CD7 arising in a background of follicular lymphoma in an 81-year-old male who presented with a nontender left axillary mass. Additionally, no other T-cell antigens were expressed in this B-cell lymphoma. Expression of CD7 in DLBCL is exceptionally rare and its prognostic significance is unknown. Here, we describe this rare case with review of literature of known DLBCLs with expression of T-cell antigens. |
Databáze: |
MEDLINE |
Externí odkaz: |
|